Tuberculosis Vaccines: Hopes and Hurdles

ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)


Volume 14, 3 Issues, 2014


Download PDF Flyer




Infectious Disorders - Drug Targets

Formerly: Current Drug Targets - Infectious Disorders

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Tuberculosis Vaccines: Hopes and Hurdles

Author(s): Mohamed J. Ahsan, Shiv K. Garg, Bharat Vashistha and Piush Sharma

Affiliation: Maharishi Arvind College of Pharmacy, Jaipur, Rajasthan 302 023, India.

Abstract

Tuberculosis (TB) remains as one of the most serious public health problems worldwide. It is one of the main causes of death in poor and developing countries, especially in sub-Saharan Africa, where it may be associated with the human immunodeficiency virus (HIV). It has been estimated that one third of the world population is infected by Mycobacterium tuberculosis (Mtb), and there were about 8.7 million new TB cases, and about 1.4 million yearly deaths due to TB in 2011. DOTS is the currently used drug therapy in TB but there is non-compliance which results in emergence of resistance. Bacille Calmette Guérin (BCG), an attenuated vaccine derived from Mycobacterium bovis, is the only licensed TB vaccine, but not recommended in HIV-infected infants. There are 14 vaccine candidates that have entered clinical trials and over 35 candidates in discovery and preclinical development. Mycobacterium indicus pranii [Mw; MIP] and M. vaccae are in phase III clinical trial and the Drug Controller of India licensed MIP for human use in India.

Keywords: Clinical trials, review, tuberculosis, tuberculosis vaccines.

Purchase Online Rights and Permissions

  
  



Article Details

Volume: 13
Issue Number: 5
First Page: 318
Last Page: 321
Page Count: 4
DOI: 10.2174/1871526513666131201125513
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science